Fortune Mate Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fortune Mate Indonesia Tbk trades at Rp254 (market cap 1.61T, 11.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 33.1K 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 9.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (33.1K versus 11.4K). Which is the better fit depends on your goals.
| FMII | OBAT | |
|---|---|---|
Market Cap | 1.61T | 167.37B |
Volume | 11.4K | 33.1K |
Lot | 114 | 331 |
Turnover | 2.84M | 8.17M |
Average Price | 249.09 | 246.91 |
Value | 2.84M | 8.17M |
Indicative Equilibrium Price | 252 | 246 |
Indicative Equilibrium Volume | 100 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →